Abstract
Maturity-onset diabetes of the young type 3 (MODY3) is caused by haploinsufficiency of hepatocyte nuclear factor-1α (encoded by TCF1). Tcf1−/− mice have type 2 diabetes, dwarfism, renal Fanconi syndrome, hepatic dysfunction and hypercholestrolemia. Here we explore the molecular basis for the hypercholesterolemia using oligonucleotide microchip expression analysis. We demonstrate that Tcf1−/− mice have a defect in bile acid transport, increased bile acid and liver cholesterol synthesis, and impaired HDL metabolism. Tcf1−/− liver has decreased expression of the basolateral membrane bile acid transporters Slc10a1, Slc21a3 and Slc21a5, leading to impaired portal bile acid uptake and elevated plasma bile acid concentrations. In intestine and kidneys, Tcf1−/− mice lack expression of the ileal bile acid transporter (Slc10a2), resulting in increased fecal and urinary bile acid excretion. The Tcf1 protein (also known as HNF-1α) also regulates transcription of the gene (Nr1h4) encoding the farnesoid X receptor-1 (Fxr-1), thereby leading to reduced expression of small heterodimer partner-1 (Shp-1) and repression of Cyp7a1, the rate-limiting enzyme in the classic bile acid biosynthesis pathway. In addition, hepatocyte bile acid storage protein is absent from Tcf1−/− mice. Increased plasma cholesterol of Tcf1−/− mice resides predominantly in large, buoyant, high-density lipoprotein (HDL) particles. This is most likely due to reduced activity of the HDL-catabolic enzyme hepatic lipase (Lipc) and increased expression of HDL-cholesterol esterifying enzyme lecithin:cholesterol acyl transferase (Lcat). Our studies demonstrate that Tcf1, in addition to being an important regulator of insulin secretion, is an essential transcriptional regulator of bile acid and HDL-cholesterol metabolism.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout








Similar content being viewed by others
Accession codes
References
Tranche, T. et al. Hepatocyte nuclear factor-1 (HNF1) and liver gene expression. in Liver Gene Expression (eds. Tronche, F. & Yaniv, M.) 155–181 (R.G. Landes, Austin, 1994).
Yamagata, K. et al. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young. Nature 384, 455–458 (1996).
Pontoglio, M. et al. Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell 84, 575–585 (1996).
Lee, Y.H., Sauer, B. & Gonzalez, F.J. Laron dwarfism and non-insulin-dependent diabetes mellitus in the Hnf-1α knockout mouse. Mol. Cell. Biol. 18, 3059–3068 (1998).
Brown, M.S. & Goldstein, J.L. The SREBP pathway: regulation of cholesterol metabolism by proteolysis by proteolysis of a membrane bound transcription factor. Cell 89, 331–340 (1997).
Muller, M. & Jansen, P.L. Molecular aspects of hepatobiliary transport. Am. J. Physiol. 272, G1285–1303 (1997).
Chawla, A., Saez, E. & Evans, R.M. Don't know much bile-ology. Cell 103, 1–4 (2000).
Meier, P.J., Eckhardt, U., Schroeder, A., Hagenbuch, B. & Stieger, B. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver. Hepatology 26, 1667–1677 (1997).
Stiewger, B. & Meier, P.J. Bile acid and xenobiotic transporters in liver. Curr. Opin. Cell. Biol. 10, 462–467 (1998).
de Vree, J.M. et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc. Natl. Acad. Sci. USA 95, 282–287 (1998).
Chiang, J.Y.L. Regulation of bile acid synthesis. Front. Biosci. 3, D176–D193 (1997).
Janowski, B.A., Willy, P.J., Devi, T.R., Falck, J.R. & Mangelsdorf, D.J. An oxysterol signaling pathway mediated by the nuclear receptor LXRa. Nature 383, 728–731 (1996).
Peet, D.J. et al. Cholesterol and bile acid metabolisms are impaired in mice lacking the nuclear oxysterol receptor LXR α. Cell 93, 693–704 (1998).
Makishima, M. et al. Identification of a nuclear receptor for bile acids. Science 284, 1362–1365 (1999).
Parks, D.J. et al. Bile acids: natural ligands for an orphan nuclear receptor. Science 284, 1365–1368 (1999).
Nitta, M., Ku, S., Brown, C., Okamoto, A.Y. & Shan, B. CPF: an orphan nuclear receptor that regulates liver-specific expression of the human cholesterol 7a-hydroxylase gene. Proc. Natl. Acad. Sci. USA 96, 6660–6665 (1999).
Goodwin, B. et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell 6, 517–526 (2000).
Lu, T.T. et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell 6, 507–515 (2000).
Sinal, C.J. et al. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102, 731–744 (2000).
Powell, D.R. & Suwanichkul, A. HNF1 activates transcription of the human gene for insulin-like growth factor binding protein-1. DNA Cell Biol. 12, 283–289 (1993).
Wong, M.H., Oelkers, P., Craddock, A.L. & Dawson, P.A. Expression cloning and characterization of the hamster ileal sodium-dependent bile acid transporter. J. Biol. Chem. 269, 1340–1347 (1994).
Christie, D.M., Dawson, P.A., Thevananther, S. & Shneider, B.L. Comparative analysis of the ontogeny of a sodium-dependent bile acid transporter in rat kidney and ileum. Am. J. Physiol. 271, G377–385 (1996).
Ishibashi, S., Goldstein, J.L., Brown, M.S., Herz, J. & Burns, D.K. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J. Clin. Invest. 93, 1885–1893 (1994).
Felker, T.E., Hamilton, R.L. & Havel, R.J. Secretion of lipoprotein-X by perfused livers of rats with cholestasis. Proc. Natl. Acad. Sci. USA 75, 3459–3463 (1978).
Manzato, E. et al. Formation of lipoprotein-X. Its relationship to bile compounds. J. Clin. Invest. 57, 1248–1260 (1976).
Norum, K.R., Glomset, J.A., Nichols, A.V. & Forte, T. Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: physical and chemical of low and high-density lipoproteins. J. Clin. Invest. 50, 1131–1140 (1971).
van Antwerpen, R. et al. Cryo-electron microscopy of low-density lipoprotein and reconstituted discoidal high density lipoprotein: imaging of the apolipoprotein moiety. J. Lipid Res. 38, 659–669 (1997).
Laggner, P. et al. The lipid bilayer structure of the abnormal human plasma lipoprotein X. An X-ray small-angle-scattering study. Eur. J. Biochem. 77, 165–171 (1977).
Austin, M.A. & Edwards, K.L. Small, dense low-density lipoproteins, the insulin resistance syndrome and noninsulin-dependent diabetes. Curr. Opin. Lipidol. 7, 167–171 (1996).
Homanics, G.E. et al. Mild dyslipidemia in mice following targeted inactivation of the hepatic lipase gene. J. Biol. Chem. 270, 2974–80 (1995).
Föger, B. et al. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice. J. Biol. Chem. 274, 36912–36920 (1999).
Mahley, R.W., Weisgraber, K.H., Innerarity, T., Brewer, H.B., Jr. & Assmann, G. Swine lipoproteins and atherosclerosis. Changes in the plasma lipoproteins and apoproteins induced by cholesterol feeding. Biochemistry 14, 2817–2823 (1975).
Stolz, A. et al. cDNA cloning of the human hepatic bile acid-binding protein. A member of the monomeric reductase gene family. J. Biol. Chem. 268, 10448–10457 (1993).
Stoffel, M. & Duncan, S.A. The maturity-onset diabetes of the young (MODY1) transcription factor HNF4α regulates expression of genes required for glucose transport and metabolism. Proc. Natl. Acad. Sci. USA 94, 13209–13214 (1997).
Ananthanarayanan, M., Bucuvalas, J.C., Shneider, B.L., Sippel, C.J. & Suchy, F.J. An ontogenically regulated 48-kDa protein is a component of the Na(+)-bile acid cotransporter of rat liver. Am. J. Physiol. 261, G810–817 (1991).
Bergwerk, A.J. et al. Immunologic distribution of an organic anion transport protein in rat liver and kidney. Am. J. Physiol. 271, G231–238 (1996).
Mendel, D.B., Hansen, L.P., Graves, M.K., Conley, P.B. & Crabtree, G.R. HNF-1 α and HNF-1 β (vHNF-1) share dimerization and homeo domains, but not activation domains, and form heterodimers in vitro. Genes Dev. 5, 1042–1056 (1991).
Setchell, K.D.R., Lawson, A.M., Tanida, N. & Sjovall, J. General methods for the analysis of metabolic profiles of bile acids and related compounds in feces. J. Lipid Res. 24, 1085–1100 (1983).
Setchell, K.D.R. et al. Δ22-Ursodeoxycholic acid, a unique metabolite of administered ursodeoxycholic acid in rats, indicating partial β-oxidation as a major pathway for bile acid metabolism. Biochemistry 34, 4169–4178 (1995).
Aalto-Setala, K. et al. Intestinal expression of human apolipoprotein A-IV in transgenic mice fails to influence dietary lipid absorption or feeding behavior. J. Clin. Invest. 93, 1776–1786 (1994).
Sehayek, E. et al. Biliary cholesterol excretion: a novel mechanism that regulates dietary cholesterol absorption. Proc. Natl. Acad. Sci. USA 95, 10194–10199 (1998).
Levine, D.M. & Williams, K.J. Automated measurements of mouse apolipoprotein B: convenient screening tool for mouse models of atherosclerosis. Clin. Chem. 43, 669–674 (1997).
Shneider, B.L. et al. Cloning and characterization of a novel peptidase from rat and human ileum. J. Biol. Chem. 272, 31006–31015 (1997).
Acknowledgements
We thank J.M. Friedman and P. Cohen for advice on gene expression analysis and for discussions; D. Levine and E. Ribary for apoB48/b100 and apoA1 measurements; A. Wolkoff for Oatp1 antibody; J. Lingutla for technical help; E. Sphicas for electron microscopy services; and R. and H. Heilbrunn and A. and F.B. Adler for support. This work was supported in part by the American Diabetes Association (M.S.), NIH grants R01DK55033-01 (M.S.), HD20632 (M.A.), DK02076 (B.S.), DK26756 (S.S.) and NIH MSTP grant GM07739 (D.Q.S.), Deutsche Studienstiftung (M.B.), Emerald Foundation (M.S.) and AMDEK.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Rights and permissions
About this article
Cite this article
Shih, D., Bussen, M., Sehayek, E. et al. Hepatocyte nuclear factor-1α is an essential regulator of bile acid and plasma cholesterol metabolism. Nat Genet 27, 375–382 (2001). https://doi.org/10.1038/86871
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/86871
This article is cited by
-
HNF1A binds and regulates the expression of SLC51B to facilitate the uptake of estrone sulfate in human renal proximal tubule epithelial cells
Cell Death & Disease (2023)
-
Copper-mediated shifts in transcriptomic responses of intestines in Bufo gargarizans tadpoles to lead stress
Environmental Science and Pollution Research (2023)
-
Epigenetic reprogramming of cell identity: lessons from development for regenerative medicine
Clinical Epigenetics (2021)
-
Tissue-specific transcription reprogramming promotes liver metastasis of colorectal cancer
Cell Research (2020)
-
Transcriptional Regulation of the Angptl8 Gene by Hepatocyte Nuclear Factor-1 in the Murine Liver
Scientific Reports (2020)